EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.1.1.60 | Adenocarcinoma, Mucinous |
30579547 |
A Novel CAMKMT Exon3-ALK Exon20 Fusion Variant was Identified in a Primary Pulmonary Mucinous Adenocarcinoma. |
unassigned |
0 |
| 2.1.1.60 | Intellectual Disability |
26247364 |
Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. |
causal interaction |
4 |
| 2.1.1.60 | Intellectual Disability |
26247364 |
Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. |
diagnostic usage |
3 |
| 2.1.1.60 | Intellectual Disability |
26247364 |
Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. |
unassigned |
0 |
| 2.1.1.60 | Muscle Weakness |
26247364 |
Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. |
causal interaction |
4 |
| 2.1.1.60 | Muscle Weakness |
26247364 |
Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. |
diagnostic usage |
3 |
| 2.1.1.60 | Muscle Weakness |
26247364 |
Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. |
unassigned |
0 |
